DR. DERRICK LONSDALE, M.D.
Marriage and Family Therapists at Center Ridge Rd, Cleveland, OH
License number
Ohio 35026171
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
24700 Center Ridge Rd SUITE 317, Cleveland, OH 44145
Phone
(440) 835-0104
(440) 835-2177 (Fax)
(440) 835-2177 (Fax)
Personal information
See more information about DERRICK LONSDALE at radaris.comName
Address
Phone
28575 Wstlk Vllage Dr Apt A106, Westlake, OH 44145
Strongsville, OH
12315 The Blf, Strongsville, OH 44136
223 Greenward Way, North Olmsted, OH 44070
24700 Center Ridge Rd, Westlake, OH 44145
Organization information
See more information about DERRICK LONSDALE at bizstanding.comDerrick Lonsdale Md - Preventive Medicine Group
24700 Ctr Rdg Rd #317, Westlake, OH 44145
Phone:
(440) 835-0104 (Phone)
Email:
SIC:
8731 - Commercial Physical and Biological Research
Professional information
See more information about DERRICK LONSDALE at trustoria.com
Dr. At Preventive Medicine Group
Dr. At Preventive Medicine Group
Location:
Cleveland/Akron, Ohio Area
Industry:
Medical Practice
Work:
Cleveland Clinic
Jun 1962 - May 1982
-
Pediatrician
Education:
St.Bartholomew's Hospital Medical College
M.B. B.S.
M.B. B.S.
Skills:
Clinical Research, Family Medicine, Genetics, Board Certified
Derrick Lonsdale, Westlake OH
Derrick Lonsdale, Westlake OH
Specialties:
Pediatrics, Family Medicine
Work:
Preventive Medicine Group
24700 Center Ridge Rd, Westlake, OH 44145
24700 Center Ridge Rd, Westlake, OH 44145
Education:
Guy's Hospital Medical School, London (1947)
Lipid-Soluble Thiamine Derivatives In The Treatment Of Autism
Lipid-Soluble Thiamine Derivatives In The Treatment Of Autism
US Patent:
6585996, Jul 1, 2003
Filed:
Mar 13, 2002
Appl. No.:
10/097914
Inventors:
Derrick Lonsdale - Strongsville OH
James P. Frackelton - Westlake OH
James P. Frackelton - Westlake OH
Assignee:
Westlake Laboratories, Inc. - Westlake OH
International Classification:
A61K 900
US Classification:
424433, 424436, 424443, 424449, 424451, 424464
Abstract:
The present invention is directed to a method for the treatment of autism comprising administering to a person in need of such treatment a therapeutically effective amount of a lipid-soluble thiamine derivative. The lipid-soluble thiamine derivative is preferably tetrahydrofurfuryl disulfide (TTFD). TTFD administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules.